Fintel reports that on August 21, 2025, HC Wainwright & Co. initiated coverage of Achieve Life Sciences (NasdaqCM:ACHV) with a Buy recommendation. Analyst Price Forecast Suggests 532.56% Upside As of ...

Fintel reports that on September 27, 2024, Raymond James initiated coverage of Achieve Life Sciences (NasdaqCM:ACHV) with a Strong Buy recommendation. As of September 25, 2024, the average one-year ...

Achieve Life Sciences (ACHV) is positioned for growth with its lead smoking cessation therapy, cytisinicline, advancing through late-stage clinical trials. The company addresses a significant unmet ...

Shares of Achieve Life Sciences, Inc. (ACHV) soared 32% on Friday afternoon after the company said that the U.S. Food and Drug Administration (FDA) awarded the company a Commissioner's National ...

Achieve Life Sciences Inc. (NASDAQ:ACHV) is moving closer to a pivotal moment as it seeks FDA approval for cytisinicline, a potential first new smoking cessation therapy in nearly two decades, ...

Achieve Life Sciences (NASDAQ:ACHV) has announced the pricing of an underwritten public offering of 15M shares of its common stock and accompanying common warrants to purchase up to 15M shares of ...